Doximity, Inc. (NASDAQ:DOCS - Get Free Report) has been assigned an average recommendation of "Hold" from the twenty ratings firms that are presently covering the firm, Marketbeat Ratings reports. Thirteen analysts have rated the stock with a hold recommendation, six have issued a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1 year price objective among brokerages that have issued ratings on the stock in the last year is $52.59.
DOCS has been the subject of a number of recent analyst reports. Truist Financial raised their target price on Doximity from $35.00 to $49.00 and gave the company a "hold" rating in a report on Thursday, November 14th. Canaccord Genuity Group restated a "hold" rating and set a $60.00 target price (up from $40.00) on shares of Doximity in a research report on Wednesday, November 13th. Mizuho assumed coverage on shares of Doximity in a research report on Wednesday, December 4th. They set a "neutral" rating and a $55.00 price target for the company. Robert W. Baird upped their price target on Doximity from $41.00 to $45.00 and gave the stock an "outperform" rating in a report on Tuesday, September 17th. Finally, The Goldman Sachs Group started coverage on Doximity in a research note on Friday, November 15th. They issued a "neutral" rating and a $58.00 price objective for the company.
View Our Latest Stock Report on DOCS
Institutional Inflows and Outflows
A number of large investors have recently bought and sold shares of DOCS. FMR LLC increased its holdings in shares of Doximity by 30.5% in the 3rd quarter. FMR LLC now owns 6,837,733 shares of the company's stock valued at $297,920,000 after acquiring an additional 1,598,602 shares during the last quarter. William Blair Investment Management LLC lifted its position in shares of Doximity by 15.8% in the 2nd quarter. William Blair Investment Management LLC now owns 6,404,068 shares of the company's stock worth $179,122,000 after buying an additional 873,682 shares during the last quarter. Clearbridge Investments LLC boosted its holdings in shares of Doximity by 7.1% in the 2nd quarter. Clearbridge Investments LLC now owns 5,853,035 shares of the company's stock valued at $163,709,000 after buying an additional 387,200 shares during the period. State Street Corp grew its position in shares of Doximity by 2.5% during the 3rd quarter. State Street Corp now owns 3,693,982 shares of the company's stock valued at $160,947,000 after buying an additional 88,922 shares during the last quarter. Finally, Geode Capital Management LLC raised its stake in Doximity by 19.8% during the third quarter. Geode Capital Management LLC now owns 2,856,984 shares of the company's stock worth $124,503,000 after acquiring an additional 472,565 shares during the period. Institutional investors own 87.19% of the company's stock.
Doximity Trading Down 1.1 %
Shares of DOCS traded down $0.64 during mid-day trading on Friday, hitting $57.78. The company's stock had a trading volume of 1,601,881 shares, compared to its average volume of 1,780,862. The firm has a 50-day simple moving average of $50.59 and a 200 day simple moving average of $39.80. Doximity has a 1-year low of $22.96 and a 1-year high of $61.75. The firm has a market capitalization of $10.79 billion, a P/E ratio of 66.41, a P/E/G ratio of 4.16 and a beta of 1.40.
Doximity Company Profile
(
Get Free ReportDoximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.
Recommended Stories
Before you consider Doximity, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Doximity wasn't on the list.
While Doximity currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.